fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Maraviroc lowers incidence of graft-versus-host disease in bone marrow transplantion

Written by | 26 Oct 2012

by Bruce Sylvester – Emerging use of FDA Approved Drugs – Maraviroc, an antiretroviral drugin the treatment of HIV, significantly reduces the incidence of graft-versus-host disease (GvHD) among… read more.

Eltrombopag shows efficacy in severe, refractory aplastic anemia

Written by | 26 Oct 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – In some patients severe aplastic anemia who have failed standard therapies, eltrombopag appears to raise blood cell… read more.

Botulinum toxin helps improve tremor associated with MS

Written by | 26 Oct 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Botulinum toxin treatment appears to improve tremor in the arms and hands of persons with multiple sclerosis… read more.

Supercomputer offers hope for improved ‘cold’ treatments

Written by | 26 Oct 2012

by Gary Finnegan – World Health Matters (Australia) – Click here for more information Melbourne researchers are using Australia’s fasted supercomputer to simulate the motion of the complete… read more.

ITS 2012 Report – Immunosuppression: What’s to come? Immunosuppression in the pipeline

Written by | 5 Oct 2012

by Maria Dalby – Efforts continue to develop new anti-rejection agents that are as effective as the calcineurin inhibitors (CNI) but without the debilitating side effects.

Pharmacological preconditioning for transplantation – Lost in translation?

Written by | 5 Oct 2012

by Professor Stephen J Wigmore – Ischaemia reperfusion injury is an inevitable consequence of the process of clinical transplantation. Organ injury and delayed function are common events after… read more.

ESMO 2012 Report – Urgent need for integrated oncology and palliative care

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.

Nanochains mark micrometastases for early diagnosis, treatment

Written by | 28 Sep 2012

Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths.

Leading cancer specialists from Europe and beyond recognized at ESMO 2012

Written by | 28 Sep 2012

The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to… read more.

Study uncovers simple way of predicting severe pain following breast cancer surgery

Written by | 28 Sep 2012

Women having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other… read more.

NSAIDs halt damage in Spinal Arthritis

Written by | 28 Sep 2012

The routine use of non-steroidal anti-inflammatory drugs (NSAIDs) among patients with ankylosing spondylitis can slow the progression of bone changes in the spine, two groups of European researchers… read more.

ESC 2012 Report – Incidence rises in heart failure after Japan’s earthquake and tsunami

Written by | 17 Sep 2012

by Zara Qadir – On March 11, 2011, Japan was shocked by the most powerful known earthquake ever to have hit Japan. The earthquake and tsunami caused 15,861… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.